pharma · Urea cycle disorders (UCD) · Cannabis Smoking · CAMP
Camp4 Therapeutics
Camp4 Therapeutics Corp
Camp4 Therapeutics clinical programs — 9 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2016
- Employees
- 60
- Programs
- 9
- Drugs
- 15
- Patents
- 4
Camp4 Therapeutics projects
9 ClinicalTrials.gov programs sponsored by Camp4 Therapeutics.
Camp4 Therapeutics has 9 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Conventional sound generator (SG)
Camp4 Therapeutics Corp
Subjective Tinnitus
1 trial -
IncobotulinumtoxinA (XEOMIN®)
Camp4 Therapeutics Corp
Chronic Migraine
1 trial -
Ketamine Hydrochloride
Camp4 Therapeutics Corp
Suicide
1 trial -
Placebo
Camp4 Therapeutics Corp
Asthma
1 trial -
Virtual Reality Exposure Therapy - Dynamic
Camp4 Therapeutics Corp
Post Traumatic Stress Disorder
1 trial -
Active smoked cannabis
Camp4 Therapeutics Corp
Cannabis Smoking
1 trial -
Treatment as Usual
Camp4 Therapeutics Corp
Post-Traumatic Stress Disorder
1 trial -
CMP-CPS-001
Camp4 Therapeutics Corp
Healthy Volunteers
1 trial -
CPS-101
Camp4 Therapeutics Corp
Urea cycle disorders (UCD)
1 trial
Frequently asked questions
How many clinical projects does Camp4 Therapeutics have?
9 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.